期刊文献+

冠心病患者血浆P-选择素、血管性假性血友病因子水平变化及临床意义 被引量:2

Changes and clinical significance of P-selectin and von Willebrand factor in patients with coronary heart disease
下载PDF
导出
摘要 目的观察冠心病患者血浆P-选择素、血管性假性血友病因子(vWF)浓度的改变并探讨其临床意义。方法分别测定28例稳定型心绞痛(SA)患者、39例不稳定型心绞痛(UA)患者、21例正常对照组体内的P-选择素、vWF含量,并分析有无冠状动脉事件发生者与P-选择素、vWF之间的关系,同时探讨P-选择素与vWF的相关关系。结果UA组P-选择素、vWF含量明显高于SA组,(13.11±4.13)μg/L vs(10.92±3.16)μg/L,(159.1±45.4)%vs(136.3±43.8)%(均P<0.05)和对照组(10.21±3.38)μg/L,(124.5±36.9)%(均P<0.05),而SA组与对照组比较差异无统计学意义(P>0.05);有冠状动脉事件发生者与无冠状动脉事件发生者比较,P-选择素(13.59±4.24)μg/L vs(11.23±3.67)μg/L和vWF(167.9±38.7)%vs(140.0±49.4)%差异均有统计学意义(P<0.05);UA患者P-选择素水平与vWF水平成正相关(r=0.331,P<0.05),有冠状动脉事件发生者二者亦呈正相关(r=0.397,P<0.05)。结论血浆P-选择素、vWF水平可作为冠状动脉血栓形成的指标之一,并在一定程度上反映了冠状动脉事件发生的危险性。 Objective To compare plasma P-seleetin and yon Willebrand faetor(vWF) concentrations in patients with coronary heart disease. Methods P-selectin and vWF in 28 patients with stable angina(SA group), 39 patients with unstable angina(UA group) ,and 21 controls(control group) were measured. The changes of P-selectin and vWF in patients with and without coronary events were compared. The correlation between P-seleetin and vWF was also analyzed. Results There were significant differences of P-selectin and vWF between UA group and SA group, (13.11 ±4.13)μg/L vs (10.92±3.16) μg/L, (159.1±45.4)% vs (136.3± 43.8)% (both P 〈0.05) or control group, (10.21± 3.38), (124.5±36.9)% (both P 〈0.05), while there was no significant difference between SA group and control group( P 〉0.05). There were also significant differences of P-seleetin and vWF between patients with coronary events and patients without coronary events, (13.59±4.24) μg/L vs (11.23± 3.67) μg/L, (167.9 ± 38.7) % vs (140.0±49.4) % ( P 〈0.05). There was a positive correlation between P-selectin and vWF level in SA group (r = 0. 331, P 〈0.05), patients with coronary events( r = 0. 397, P 〈0.05). Conclusion P-seleetin and vWF may be regarded as the indexes of coronary thrombosis and used for predicting the severity of coronary events.
出处 《临床荟萃》 CAS 2009年第4期307-309,共3页 Clinical Focus
关键词 冠状动脉疾病 P选择素 yon WILLEBRAND因子 冠状血管造影术 coronary heart disease P-seleetin von Willebrand factor coronary angiography
  • 相关文献

参考文献9

  • 1Davies MJ. Pathophysiology of acute coronary syndromes[J]. Indian Heart J,2000,52(4) : 473-479.
  • 2Yazici M, Demircan S, Durna K, et al. Relationship between myocardial injury and soluble P -selectin in non-ST elevation acute coronary syndromes[J]. Circ J,2005,69(5) :530-535.
  • 3Libby P. Changing concepts of atherogenesis[J]. J Intern Med, 2000,247(3) : 349-358.
  • 4Soeki T, Tamura Y, Shinohara H, et al. Increased soluble platelet/endothelial cell adhesion molecule - 1 in the early stages of acute coronary syndromes[J]. Int J Cardiol,2003,90(2/3) : 261-268.
  • 5Schumaeher A,Seljeflot I, Sommervoll L, et al. Increased levels of endothelial haemostatic markers in patients with coronary heart disease[J]. Thromb Res, 2002,105 ( 1 ) : 25-31.
  • 6富路,赵艳红,傅世英.假性血友病因子与冠心病[J].心血管病学进展,2002,23(2):102-105. 被引量:3
  • 7Heper G, Bayraktaroglu M. The importance of yon Willebrand factor level and heart rate changes in acute coronary syndrome: a comparison with chronic ischemic conditions [J]. Angiology, 2003,54(3) :287-299.
  • 8陈美娟,屈晓冰,陈珑珑,胡信群.急性冠状动脉综合征患者血管性血友病因子水平及与冠状动脉病变的关系[J].中国动脉硬化杂志,2004,12(6):698-700. 被引量:4
  • 9Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis[J]. J Pharmaeol Exp Ther, 2002,300 (3) : 729- 735.

二级参考文献27

  • 1袁洪,李轶男,张梦玺.老年高血压病患者血管内皮损伤、血小板活化及炎症因子的改变[J].中国动脉硬化杂志,2001,9(3):255-256. 被引量:12
  • 2[1]Hamsten A. The heamostatic system and coronary heart disease[J]. Thromb Res, 1993,70(1): 1-38.
  • 3[2]Tit ani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor[J ]. Biochemistry, 1986,25: 3171-3176.
  • 4[3]Jean-Pierre Girma JP,Meyer D,Veraeij,CL,et al. Structure-Function rela tionship of human von Willebrand factor[J]. Blood,1987,70(3):605-611.
  • 5[4]Stel HV, Sakariassen KS, de Groot PG, et al. von Willebrand factor in the vessel wall mediates plate let adherence[J]. Blood,1985,65:85-89.
  • 6[5]Eto K, Isshiki T, Yamamoto H ,et al. AjvW-2 ,an anti-vWF monoclonal antibody,inhibits enhanced platelet aggregation induced by high shear stress inplatelet-rich plasma from patients with acute coronary syndromes[J]. Arteriosclet Thromb Vasc Biol, 1999,19 (4): 877-882.
  • 7[6]Fressomaid E,Sakariassen KS, Girma JP,et al. Role of Gp Ⅱ b/Ⅲ a as well as Gplb in von Willebrand factor-mediated platelet adhesion to collagen[J]. Thromb Res, 1986,6 : 138-141.
  • 8[7]Houdijk WPM, Sakariassen KS, Nievelstein PFEM, et al. Role of factor Ⅷ von Willebrand factor and fibrouectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types Ⅰ and Ⅲ [J]. JClin Invest, 1985,75:531-536.
  • 9[8]Blann AD,Dobrotova M,Kubisz P,et al. von Willebrand factor,soluble P-selection, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis [ J]. Thromb Haemost , 1995.74 (2): 626-630.
  • 10[9]Federici AB,Berkowitz SD,Zimmerman TS,et al. Proteolysis of von Wille brand factor after thrombolytic therapy in patients with acute myocardial in farction[J]. Blood, 1992, 79 (1): 38-44.

共引文献5

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部